Corrao, G.; Franchi, M.; Cereda, D.; Bortolan, F.; Leoni, O.; Borriello, C.R.; Della Valle, P.G.; Tirani, M.; Pavesi, G.; Barone, A.;
et al. Vulnerability Predictors of Post-Vaccine SARS-CoV-2 Infection and Disease—Empirical Evidence from a Large Population-Based Italian Platform. Vaccines 2022, 10, 845.
https://doi.org/10.3390/vaccines10060845
AMA Style
Corrao G, Franchi M, Cereda D, Bortolan F, Leoni O, Borriello CR, Della Valle PG, Tirani M, Pavesi G, Barone A,
et al. Vulnerability Predictors of Post-Vaccine SARS-CoV-2 Infection and Disease—Empirical Evidence from a Large Population-Based Italian Platform. Vaccines. 2022; 10(6):845.
https://doi.org/10.3390/vaccines10060845
Chicago/Turabian Style
Corrao, Giovanni, Matteo Franchi, Danilo Cereda, Francesco Bortolan, Olivia Leoni, Catia Rosanna Borriello, Petra Giulia Della Valle, Marcello Tirani, Giovanni Pavesi, Antonio Barone,
and et al. 2022. "Vulnerability Predictors of Post-Vaccine SARS-CoV-2 Infection and Disease—Empirical Evidence from a Large Population-Based Italian Platform" Vaccines 10, no. 6: 845.
https://doi.org/10.3390/vaccines10060845
APA Style
Corrao, G., Franchi, M., Cereda, D., Bortolan, F., Leoni, O., Borriello, C. R., Della Valle, P. G., Tirani, M., Pavesi, G., Barone, A., Ercolanoni, M., Jara, J., Galli, M., & Bertolaso, G.
(2022). Vulnerability Predictors of Post-Vaccine SARS-CoV-2 Infection and Disease—Empirical Evidence from a Large Population-Based Italian Platform. Vaccines, 10(6), 845.
https://doi.org/10.3390/vaccines10060845
